SCHEMBL775219

SCHEMBL775219

CC(F)(F)C([O])(F)F

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4950749 0.80
SCHEMBL337086 0.80
SCHEMBL4953730 0.79
SCHEMBL80383 0.78
SCHEMBL28521 0.78
SCHEMBL3196363 0.76
SCHEMBL7501319 0.73
SCHEMBL5170484 0.73
SCHEMBL21487190 0.73
SCHEMBL21488571 0.73

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 207 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118234706-A Substituted sulfite compound and preparation method and application thereof 青岛康乔药业集团有限公司 2024-06-21 CN claimed
CN-117800987-A Cephalosporin compound and application thereof in preparation of antibacterial drugs 复旦大学 2024-04-02 CN claimed
CN-117327000-A Biphenyl tetrahydropyrrole compound and preparation method and application thereof 海南因瑞生物医药科技有限公司 2024-01-02 CN claimed
CN-115232129-B PARP1 selective inhibitor and preparation method and application thereof 上海闻耐医药科技有限公司 2023-12-01 CN claimed
CN-115232129-A PARP1 selective inhibitor and preparation method and application thereof 上海闻耐医药科技有限公司 2022-10-25 CN claimed
US-8318209-B2 microspheres; inner core is polymethyl methacrylate hydrogel polymer and a contrast agent; outer polyphosphazene coating; poly[bis(2,2,2-trifluoroethoxy)phosphazene]; size of particle allows selective embolization of certain blood vessels; fluoroscopy, tomography CELONOVA BIOSCIENCES GERMANY GMBH (DE) 2012-11-27 US claimed
WO-2011032159-A1 METHODS TO PREVENT A HAIR-RELATED SIDE EFFECT OF TREATMENT WITH A CHEMOTHERAPEUTIC AGENT META COMESTICS, LLC (US) 2011-03-17 WO claimed
US-20110002866-A1 METHODS TO PREVENT A HAIR-RELATED SIDE EFFECT OF TREATMENT WITH A CHEMOTHERAPEUTIC AGENT LUBIT BEVERLY W 2011-01-06 US claimed
EP-1284267-B1 TRIAZOLE COMPOUNDS HAVING AMIDE LINKAGE SANKYO CO (JP) 2004-12-15 EP claimed
US-20040058903-A1 Benzamide compounds as apo b secretion inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2004-03-25 US claimed
EP-1326835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2003-07-16 EP claimed
EP-0889881-B1 NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS NAEJA PHARMACEUTICAL INC (CA) 2003-04-23 EP claimed
EP-1284267-A1 TRIAZOLE COMPOUNDS HAVING AMIDE LINKAGE Sankyo Company, Limited (JP) 2003-02-19 EP claimed
EP-1278755-A2 AZOLE COMPOUNDS AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS Ranbaxy Laboratories, Limited (IN) 2003-01-29 EP claimed
WO-2002028835-A1 BENZAMIDE COMPOUNDS AS APO B SECRETION INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-04-11 WO claimed
WO-2001066551-A2 AZOLE COMPOUNDS AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS RANBAXY LABORATORIES LIMITED (IN) 2001-09-13 WO claimed
US-6153616-A Triazoles as therapeutic agents for fungal infections SYNPHAR LABORATORIES, INC. (CA) 2000-11-28 US claimed
EP-0889881-A1 NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS SYNPHAR LABORATORIES INC. (CA) 1999-01-13 EP claimed
WO-1998031675-A1 NEW TRIAZOLES AS THERAPEUTIC AGENTS FOR FUNGAL INFECTIONS SYNPHAR LABORATORIES, INC. (US) 1998-07-23 WO claimed
US-4957934-A AROMATASE INHIBITORS, TREATMENT OF STEROID HORMONE DEPENDENT DISEASES IMPERIAL CHEMICAL INDUSTRIES PLC (GB) 1990-09-18 US claimed